All Stories

  1. Metabolomic insights into pathophysiological mechanisms and biomarker discovery in clear cell renal cell carcinoma

    Article • Expert Review of Molecular Diagnostics, May 2019, Taylor & Francis

    Dr Giuseppe Lucarelli

  2. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update

    Article • Expert Review of Molecular Diagnostics, April 2019, Taylor & Francis

    Dr Giuseppe Lucarelli

  3. The emerging role of obesity, diet and lipid metabolism in prostate cancer

    Article • Future Oncology, February 2017, Future Medicine

    Dr Giuseppe Lucarelli

  4. Biomarkers in localized prostate cancer

    Article • Future Oncology, February 2016, Future Medicine

    Dr Giuseppe Lucarelli

  5. Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell–Renal Cell Carcinoma

    Article • Medicine, November 2015, Wolters Kluwer Health

    Dr Giuseppe Lucarelli

  6. Pre-existing Type 2 Diabetes Mellitus Is an Independent Risk Factor for Mortality and Progression in Patients With Renal Cell Carcinoma

    Article • Medicine, December 2014, Wolters Kluwer Health

    Dr Giuseppe Lucarelli

  7. Editorial Comment from Dr Lucarelli and Dr Ditonno to Impact of graft nephrectomy on outcomes of second kidney transplantation

    Article • International Journal of Urology, May 2014, Wiley

    Dr Giuseppe Lucarelli